Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1985-10-17
|
pubmed:abstractText |
Activity of ticarcillin combined with clavulanic acid against 203 P. aeruginosa strains was studied. 159 strains produced a constitutive beta-lactamase with resistance to ticarcillin (MIC less than 128 mg/l) as a result. Minimal inhibitory concentrations (MICs) were determined using the agar dilution method for ticarcillin alone and combined with 4 and 8 mg/l clavulanic acid. Addition of clavulanic acid failed to change the activity of ticarcillin on ticarcillin-susceptible stains and on strains producing a constitutive cephalosporinase. A synergic effect was demonstrated for PSE and TEM type beta-lactamase producers and for OXA type beta-lactamase producers (4 halving dilutions and 1 to 2 halving dilutions respectively). However, because of the levels of baseline MICs, the combination brought the MIC of ticarcillin below the cutoff level for a small percentage of PSE strains (6%), moderate percentage of OXA strains (17 to 50%) and significant percentage of TEM strains. These percentages were slightly higher with 8 mg than 4 mg clavulanic acid. Given current data on the prevalence of the various beta-lactamases among resistant strains now being isolated in France, the ticarcillin + clavulanic acid combination will enable to achieve an MIC less than 128 mg/l for 11% (with 4 mg) or 16% (with 8 mg) of resistant strains.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Clavulanic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Clavulanic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Penicillins,
http://linkedlifedata.com/resource/pubmed/chemical/Ticarcillin,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactamases
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0369-8114
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
408-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3929218-Clavulanic Acid,
pubmed-meshheading:3929218-Clavulanic Acids,
pubmed-meshheading:3929218-Drug Interactions,
pubmed-meshheading:3929218-Microbial Sensitivity Tests,
pubmed-meshheading:3929218-Penicillin Resistance,
pubmed-meshheading:3929218-Penicillins,
pubmed-meshheading:3929218-Phenotype,
pubmed-meshheading:3929218-Pseudomonas aeruginosa,
pubmed-meshheading:3929218-Ticarcillin,
pubmed-meshheading:3929218-beta-Lactamases
|
pubmed:year |
1985
|
pubmed:articleTitle |
[In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
|
pubmed:publicationType |
Journal Article,
English Abstract
|